Wall Street Hits Record Highs As Rate Cut Bets Offset Shutdown: This Week In Markets

U.S. equities surged to fresh record highs across major indices, including the S&P 500, Nasdaq 100, and Dow Jones Industrial Average, largely disregarding a government shutdown and absent jobs report. The rally was primarily fueled by heightened investor expectations for Federal Reserve interest rate cuts, supported by private data indicating labor market softening, alongside robust performance in pharmaceutical and AI-driven technology stocks. Notably, Pfizer's landmark drug pricing deal with the Trump administration and NVIDIA's ascent to a $4.6 trillion market capitalization underscored the sector-specific optimism driving broader market gains.

Analysis

Wall Street soared to fresh record highs at the end of the week, brushing aside the 21st U.S. government shutdown in history and a missing jobs report, as investors doubled down on bets for interest rate cuts and cheered strong gains in pharmaceutical and AI-driven tech stocks. PFE is trading in a tight range. Check the full analysis here. The S&P 500, Nasdaq 100, Dow Jones Industrial Average and Russell 2000 all reached record highs on Friday, as traders largely ignored the budget impasse in Washington and focused instead on corporate optimism and monetary easing. The Bureau of Labor Statistics failed to publish its monthly jobs report on Friday due to the shutdown, but markets leaned heavily on private data pointing to labor market softening. The ADP Employment Report showed the largest private-sector job loss in over two years, while the ISM Services PMI recorded its fourth consecutive month of contraction in its employment component. These signs reinforced expectations that the Federal Reserve could lower again its benchmark rate to 3.75%-4% at its October meeting, further fueling risk appetite. Read Also: Amazon, Meta Beware: The AI Spending Boom Is Pushing Tech Firms Into A Debt Spiral Health Care Stocks Notch Best Rally In Years Healthcare stocks were among the top performers. Pfizer Inc. (NYSE:PFE) soared after striking a landmark deal with President Donald Trump‘s administration. The agreement commits Pfizer to apply most-favored-nation pricing — aligning U.S. Medicaid drug prices with the lowest prices paid by other developed nations. In exchange, the company will avoid tariffs on branded drugs for three years. Additionally, Pfizer pledged a $70 billion investment in U.S. manufacturing and will participate in TrumpRx.gov, a new government-backed drug discount platform. The deal is seen as a possible template for the rest of the pharmaceutical industry. Shares of Eli Lilly & Co. (NYSE:LLY), Thermo Fisher Scientific Inc. (NYSE:TMO), Merck & Co. Inc (NYSE:MRK) and Amgen Inc. (NASDAQ:AMGN) all logged double-digit gains over the week. The AI-driven tech rally rolled on, with NVIDIA Corp. (NASDAQ:NVDA) hitting a staggering $4.6 trillion market capitalization, driving the total value of the so-called Magnificent Seven tech giants to $21 trillion. Risk appetite spilled into speculative assets as well. Bitcoin climbed above $121,000, nearing its August highs. Automakers Diverge Shares of Michigan automakers saw a mixed performance. General Motors Co. (NYSE:GM) fell 3% despite EV sales doubling from 2024, Ford Motor Co. (NYSE:F) rose 5% and Stellantis N.V. (NYSE:STLA) surged 14% as sales rose after eight quarters of declines. GM, Ford and Stellantis reported year-over-year sales growth of 8%, 8.2% and 6%, respectively, in the latest quarter. Read Now: Photo: Shutterstock © 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved. U.S. equity markets surged to record highs, with the S&P 500, Nasdaq 100, Dow Jones, and Russell 2000 all reaching new peaks. This broad-based rally is primarily fueled by investor conviction that the Federal Reserve will implement further interest rate cuts, targeting a benchmark rate of 3.75%-4% at its October meeting. This expectation is underpinned by weak private labor market data, specifically the largest private-sector job loss in over two years reported by ADP and a fourth consecutive month of contraction in the ISM Services PMI employment component, leading market participants to disregard headwinds such as the U.S. government shutdown. Sector-specific catalysts provided significant momentum. The healthcare sector experienced its best rally in years, led by Pfizer (PFE), which secured a landmark deal with the Trump administration to apply most-favored-nation pricing for Medicaid, avoiding tariffs and committing to a $70 billion U.S. investment. This agreement is viewed as a potential template for the industry, boosting shares of Eli Lilly (LLY), Merck (MRK), and Amgen (AMGN) by double-digits. Concurrently, the AI-driven technology rally continued, with NVIDIA (NVDA) reaching a $4.6 trillion market capitalization. In contrast, the automotive sector showed divergence; Stellantis (STLA) surged 14% on its first sales increase in eight quarters, while General Motors (GM) fell 3% despite reporting an 8% year-over-year sales growth and a doubling of EV sales.

Key Decisions for Investors

• The market's current trajectory is highly dependent on a dovish Federal Reserve pivot; investors should closely monitor upcoming inflation data and Fed communications, as any hawkish surprise could unwind recent gains.
• The Pfizer deal structure may serve as a new paradigm for the pharmaceutical sector, potentially reducing regulatory risk; consider increasing exposure to large-cap pharma names that could benefit from similar agreements.
• While the AI rally led by NVIDIA remains a primary market driver, investors should note the referenced risk of a 'debt spiral' for tech firms funding AI expansion and consider selectively trimming positions in names with stretched valuations or weakening balance sheets.
• The divergent performance of automakers, with GM's stock falling despite strong sales data, underscores the importance of company-specific analysis over broad sector bets; scrutinize individual automaker profitability, cost structures, and EV transition execution.